TITLE

COMMENTARY: Long-term use of combination DMARDs did not sustain disease remissions, but delayed joint damage in early rheumatoid arthritis

AUTHOR(S)
Sander, Oliver
PUB. DATE
January 2005
SOURCE
ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports that long-term use of combination disease-modifying antirheumatic drugs (DMARDs) did not sustain disease remissions, but delayed joint damage in early rheumatoid arthritis. In 1990s, the benefit of combination therapy with methotrexate, sulfasalazine and antimalarials was seen. Side effects of these combinations have remained problematic, however. Early, aggressive therapy can improve function and reduce inflammation, radiology damage, loss of function and mortality.
ACCESSION #
15851774

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics